Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.38 |
| ▸ | CES1 | P23141 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | CA3 | P07451 | 1/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 4/20 | 0.35 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | CA4 | P22748 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.34 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.34 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.34 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29716720 | 1.00 | CES2 (0.38) | CES2CES1CA9CA3CA6 | |
| SCHEMBL29919382 | 0.97 | CES2 (0.36) | CES2CES1CA9CA3CA6 | |
| SCHEMBL368571 | 0.97 | CES2 (0.36) | CES2CES1CA9CA3CA6 | |
| SCHEMBL8986519 | 0.92 | CES2 (0.33) | CES2CES1CA9CA3CA6 | |
| Chloroform SCHEMBL9256697 | 0.89 | ADRA2A (0.34) | CES2CES1CA9CA3CA6 | |
| SCHEMBL516276 | 0.83 | CA9 (0.37) | CES2CES1CA9CA3CA6 | |
| Trifluoroacetic Acid SCHEMBL7263980 | 0.82 | CES1 (0.37) | CES2CES1CA9CA3CA6 | |
| SCHEMBL5509678 | 0.81 | CES2 (0.38) | CES2CES1CA9CA3CA6 | |
| SCHEMBL67874 | 0.79 | CA3 (0.36) | CA9CA3CA6CA5ACA14 | |
| SCHEMBL515819 | 0.79 | CES2 (0.36) | CES2CES1CA9CA3CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1364 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12606575-B2 | Method for synthesizing zirconium complex | JFE ENGINEERING CORPORATION (JP) | 2026-04-21 | — | — | US | claimed |
| EP-4678240-A2 | BRIDGE LINKERS FOR CONJUGATION OF CELL-BINDING MOLECULES | Hangzhou Dac Biotech Co., Ltd. (CN) | 2026-01-14 | — | — | EP | claimed |
| EP-3319936-B1 | BRIDGE LINKERS FOR CONJUGATION OF CELL-BINDING MOLECULES | HANGZHOU DAC BIOTECH CO LTD (CN) | 2025-12-17 | — | — | EP | claimed |
| US-12496351-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2025-12-16 | — | — | US | claimed |
| US-20250361399-A1 | FLUORESCENT DYES WITH LARGE STOKES SHIFT | ROCHE MOLECULAR SYSTEMS INC (US) | 2025-11-27 | — | — | US | claimed |
| US-12472265-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2025-11-18 | — | — | US | claimed |
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2025-11-06 | — | — | US | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| US-12433950-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2025-10-07 | — | — | US | claimed |
| US-12351890-B2 | Method for synthesizing zirconium complex | JFE ENGINEERING CORPORATION (JP) | 2025-07-08 | — | — | US | claimed |
| US-4956276-A | FORMATION OF FLUORIDE ION FROM FLUORINATED AROMATIC COMPOUMD IN THE PRESENCE OF OXYGEN AND PEROXIDASE | BATTELLE MEMORIAL INSTITUTE (CH) | 1990-09-11 | — | — | US | claimed |
| EP-0384769-A2 | Protein labelling | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 1990-08-29 | — | — | EP | claimed |
| US-4937186-A | Method for the determination of bilirubin in solution | SCHIAPPARELLI BIOSYSTEMS, INC. | 1990-06-26 | — | — | US | claimed |
| EP-0215824-B1 | ANALYTIC METHOD FOR THE DETERMINATION OF A REDUCED COENZYME | Pharmacia ENI Diagnostics Inc. (US) | 1990-01-03 | — | — | EP | claimed |
| WO-1989007153-A1 | A METHOD FOR THE DETERMINATION OF BILIRUBIN IN SOLUTION | ELECTRO-NUCLEONICS, INC. (US) | 1989-08-10 | — | — | WO | claimed |
| EP-0326524-A2 | A method for the determination of bilirubin in solution | SCHIAPPARELLI BIOSYSTEMS, INC. (US) | 1989-08-02 | — | — | EP | claimed |
| EP-0160379-B1 | 2,3,5,6-TETRAFLUOROPHENYL (METH)ACRYLATES AND THEIR PRODUCTION | Nippon Shokubai Kagaku Kogyo Co., Ltd (JP) | 1988-06-29 | — | — | EP | claimed |
| EP-0215824-A1 | ANALYTIC METHOD FOR THE DETERMINATION OF A REDUCED COENZYME. | BATTELLE MEMORIAL INSTITUTE (CH) | 1987-04-01 | — | — | EP | claimed |
| WO-1986005517-A1 | ANALYTIC METHOD FOR THE DETERMINATION OF A REDUCED COENZYME | BATTELLE MEMORIAL INSTITUTE (CH) | 1986-09-25 | — | — | WO | claimed |
| EP-0160379-A1 | 2,3,5,6-tetrafluorophenyl (meth)acrylates and their production | Nippon Shokubai Kagaku Kogyo Co., Ltd (JP) | 1985-11-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606575-B2 | Method for synthesizing zirconium complex | CA1, TFRC, CA7 | CES2 1927/4885CES1 2003/4885CA9 13/4885 |
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | FCGR2A, FCGR3B, FCGR1A | CES2 829/4885CES1 1195/4885CA9 179/4885 |
| US-12433950-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | CD2BP2, DCLRE1A, EPCAM | CES2 346/4885CES1 1367/4885CA9 1674/4885 |
| US-12496351-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | CD2BP2, DCLRE1A, EPCAM | CES2 346/4885CES1 1367/4885CA9 1674/4885 |
| US-12472265-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | CD2BP2, DCLRE1A, EPCAM | CES2 346/4885CES1 1367/4885CA9 1674/4885 |
| US-12351890-B2 | Method for synthesizing zirconium complex | ZFP3, SLC39A3, SLC30A7 | CES2 4510/4885CES1 3857/4885CA9 128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.